Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3.
Overview
publication date
- March 26, 2020
published in
- Blood Journal
Research
keywords
- Brain
- Janus Kinase 2
- Leptin
- Protein Kinase Inhibitors
- Pyrazoles
- STAT3 Transcription Factor
- Signal Transduction
Identity
Scopus Document Identifier
- 85082561314
Digital Object Identifier (DOI)
- 10.1182/blood.2019003050
PubMed ID
- 32047890
Additional Document Info
has global citation frequency
volume
- 135
issue
- 13